Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.11% | 148.37 | 0.7% | $877.32m | |
| BMY | Bristol-Myers Squibb Co. | -4.05% | 64.16 | 1.0% | $804.09m | |
| PFE | Pfizer Inc. | -2.16% | 39.83 | 0.9% | $667.18m | |
| MRK | Merck & Co., Inc. | -2.93% | 85.97 | 0.7% | $647.43m | |
| ABBV | AbbVie, Inc. | -2.01% | 83.56 | 2.3% | $617.98m | |
| LLY | Eli Lilly & Co. | -1.55% | 139.02 | 1.1% | $425.04m | |
| NVS | Novartis AG | -1.11% | 93.87 | 0.2% | $145.91m | |
| GSK | GlaxoSmithKline Plc | -1.22% | 47.24 | 0.2% | $112.00m | |
| APLS | Apellis Pharmaceuticals, Inc. | -2.34% | 41.30 | 0.0% | $110.32m | |
| AZN | AstraZeneca Plc | -1.83% | 49.28 | 1.2% | $101.75m | |
| KRTX | Karuna Therapeutics, Inc. | 0.00% | 99.75 | 0.0% | $73.45m | |
| NVO | Novo Nordisk A/S | -0.81% | 61.09 | 0.1% | $72.43m | |
| SNY | Sanofi | -1.75% | 48.73 | 0.2% | $63.37m | |
| RETA | Reata Pharmaceuticals, Inc. | -6.45% | 193.49 | 3.5% | $59.40m | |
| ENDP | Endo International Plc | -10.24% | 5.92 | 8.8% | $43.86m |
Company Profile
Horizon Pharmaceutical LLC develops transformative treatments for people affected by rare and debilitating diseases. It offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults and for six years and older children. The company was founded by Christopher M. Starr and Todd C. Zankel in 2006 and is headquartered in Novato, CA.